PLUS1
Period:
Draw Mode:
| Volume | 823,913 |
|
|||||
| News | - | ||||||
| Day High | 1.30 | Low High |
|||||
| Day Low | 1.25 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Xeris Biopharma Holdings Inc | XERS | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.28 | 07:41:48 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.28 | 1.25 | 1.30 | 1.28 | 1.28 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,165 | 823,913 | US$ 1.26 | US$ 1,041,454 | - | 0.9701 - 2.885 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:47:43 | 4 | US$ 1.26 | USD |
Xeris Biopharma Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 175.73M | 137.29M | 122.83M | US$ 110.25M | US$ -92.41M | -0.70 | 20.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | 2.87M | 5.50% |
Xeris Biopharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 09/3/2023 | 08:29 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
| 08/3/2023 | 23:21 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 08/3/2023 | 22:00 | Business Wire | Xeris Biopharma Reports Fourth Quarter and Full-Year 2022.. |
| 23/2/2023 | 23:00 | Business Wire | Xeris Biopharma to Report Fourth Quarter and Full-Year 2022.. |
| 15/2/2023 | 04:15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 11/2/2023 | 01:05 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 02/2/2023 | 23:00 | Business Wire | Xeris Biopharma to Participate in the SVB Securities Global.. |
| 02/2/2023 | 08:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 02/2/2023 | 08:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 30/1/2023 | 23:58 | Dow Jones News | Xeris Biopharma Gets Orphan-Drug Exclusivity for Recorlev |
| 30/1/2023 | 23:00 | Business Wire | Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity.. |
| 21/1/2023 | 08:13 | Edgar (US Regulatory) | Current Report Filing (8-k) |
Historical XERS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.29 | 1.39 | 1.25 | 1.32 | 781,893 | -0.01 | -0.78% |
| 1 Month | 1.22 | 1.56 | 1.13 | 1.34 | 1,172,308 | 0.06 | 4.92% |
| 3 Months | 1.22 | 1.56 | 0.9701 | 1.24 | 1,156,530 | 0.06 | 4.92% |
| 6 Months | 1.51 | 1.70 | 0.9701 | 1.31 | 943,646 | -0.23 | -15.23% |
| 1 Year | 2.88 | 2.885 | 0.9701 | 1.69 | 1,143,696 | -1.60 | -55.56% |
| 3 Years | 1.70 | 7.94 | 0.9701 | 3.29 | 2,122,268 | -0.42 | -24.71% |
| 5 Years | 15.75 | 27.9826 | 0.9701 | 3.62 | 1,424,456 | -14.47 | -91.87% |